| 摘要: | 
			 
		     | 目的 探讨不同人绒毛膜促性腺激素(HCG)水平妊娠滋养细胞肿瘤患者的临床特点与治疗措施。 方法    收集 56 例妊娠滋养细胞肿瘤患者的资料,根据入院时血清 HCG 值分为低水平组(27 例)和高水平组(29 例),比较两组患者在发病时间、临床 表现、临床分期及治疗疗效等方面的差异。 结果    两组患者诊断 GTN 距末次妊娠时间差异有统计学意义(P<0.05)。低水平组患者 出现阴道流血症状的概率明显高于高水平组,差异有统计学意义(P<0.05)。两组患者临床分期的差异有统计学意义(P<0.05),预后 评分差异无统计学意义(P >0.05)。高水平组患者肺转移率明显高于低水平组,差异有统计学意义(P<0.05)。两组患者化疗时耐药发 生率的差异无统计学意义(P >0.05),但高水平组患者平均疗程长于低水平组,差异有统计学意义(P<0.05)。 结论    不同水平的 GTN 患者在临床特征及治疗时间上存在一定的差异,但只要选择合理的化疗方案,必要时辅以手术治疗,均可获得良好的治疗效果。 | 
			
	         
				| 关键词:  妊娠滋养细胞肿瘤    绒毛膜促性腺激素    化疗    手术治疗 | 
			 
                | DOI: | 
            
                | 分类号: | 
			 
             
                | 基金项目: | 
          |  | 
           
                | Characteristics   of   gestational   trophoblastic   neoplasia   with   different   levels   of   human   chorionic   gonadotropin | 
           
			
                | ZHOU Xiaoxu,QIAN Jianhua,ZHANG Peiwen,DING Yuan | 
           
		   
		   
                | Hangzhou First  People’s Hospital Affliated to Nanjing Medical University | 
		   
             
                | Abstract: | 
			
                | Objective    To review the clinical characteristics and treatment of gestational trophoblastic neoplasia (GTN) with different levels of human chorionic gonadotropin (HCG).    Methods    Fifty six patients with GTN were enrolled in the study, including 27  cases  with  low  HCG  level  and  29 cases  with  high  HCG  levels.  The  onset, manifestations, stage and  clinical  efficacy  were compared  between  two  groups.    Results    The  interval  between  antecedent  pregnancies  and  GTN  had  statistically  significant differences between the patients with different levels of HCG (P<0.05). The incidence of vaginal bleeding in patients with low HCG levels was higher than that in patients with high HCG levels (P<0.05). There was significant difference in distribution of GTN stages between two groups  (P<0.05), while there was no difference in prognosis score between two groups  (P >0.05). There was also significant difference in the incidence of lung metastasis between two groups (P<0.05). There was no difference in drug resistance between two groups   (P >0.05), but patients with high HCG levels required more courses of chemotherapy than those with low HCG levels  (P<0.05).    Conclusion    There are some differences in clinical features and treatment for GTN patients with different levels of HCG, but all patients can obtain satisfactory outcomes if they receive appropriate chemotherapy and surgical treatment. | 
	       
                | Key words:  Gestational trophoblastic neoplasia    Human chorionic gonadotropin    Chemotherapy    Surgery |